This Viewpoint asks what is the maximum that can be done to prevent vision loss in patients with diabetic macular edema.
This case series reports clinical outcomes after intravitreous injection of brolucizumab, 6 mg, for neovascular age-related macular degeneration.
An elderly man with a history of Philadelphia chromosome–positive acute lymphocytic leukemia, diabetes, and dementia presented with decreased visual acuity and hypopyon in his right eye. What would you do next?
This mendelian randomization and cohort study evaluated associations of tuberculosis with several noninfectious uveitis conditions, particularly Behçet disease, in cohorts in China and Japan, including a subgroup given T-SPOT.TB assays.
This prognostic study develops a predictive model in which Scheimpflug tomographic imaging is used to evaluate edema resolution after Descemet membrane endothelial keratoplasty in patients with advanced Fuchs dystrophy.
This cohort study evaluates the sensitivity and specificity of temporal artery biopsy frozen vs permanent section pathology results for giant cell arteritis and determines the discordance rate of bilateral temporal artery biopsies.
This cross-sectional study assesses the prevalence and factors associated with eyeglass wear compliance for a school year among preschool children who have a failed vision screening, are from low-income families, and receive eyeglasses through the See Well to Learn program.
A 49-year-old man presents with acute unilateral painless vision loss, antisynthetase syndrome, fever, and interstitial lung disease. What would you do next?
This cross-sectional study examines the association between vision impairment or eye disease and quality of life and the outcome of ophthalmic interventions on quality of life globally and across the life span.
This cohort study uses data from the Korean National Health Insurance Service database from 2002 to 2015 to estimate temporal trends in the incidence rates of central retinal artery occlusion among residents of Korea.
An 82-year-old man presents with a history of bilateral nuclear sclerotic cataracts and blurred vision in the right eye after cataract extraction 8 weeks earlier. On examination, his best-corrected visual acuity is 20/80 OD and 20/20 OS with a few guttate in the left eye, and central corneal thickness is 957 and 547 μm in the right and left eyes, respectively. What would you do next?
This economic evaluation assesses whether use of nonpatient vision utilities and a maximum limit model constraining vision utility gain to the systemic comorbidity utility level biases against ophthalmic cost-utility outcomes among patients with neovascular age-related macular degeneration and cataract.
This case-control study assesses the rates of retinal thinning in adults with and without sickle cell retinopathy using spectral-domain optical coherence tomography and examines ocular and systemic risk factors associated with retinal thinning.
Three weeks after uneventful pars plana vitrectomy of the right eye for vitreomacular traction, a 71-year-old woman presents with a painless central scotoma and worsening floaters. Optical coherence tomography shows atrophy, full-thickness hyperreflectivity, and a residual epiretinal membrane. What would you do next?
Create a personal account or sign in to: